Christine Ocampo insider trades: Novus Therapeutics (NVUS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Christine reports to the SEC
Open-market buys and sales
20 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 10, 2017 | NVUS | ↑ Buy | 10,010 | $9.99 | $100K | Direct | May 11, 2017 (1d) |
| Dec 18, 2014 | AVNR | ↓ Sell | 35,780 | $16.94 | $606K | Direct | Dec 18, 2014 (0d) |
| Oct 24, 2014 | AVNR | ↓ Sell | 2,080 | $11.81 | $25K | Direct | Oct 24, 2014 (0d) |
| Sep 15, 2014 | AVNR | ↓ Sell | 55,000 | $9.45 | $520K | Direct | Sep 17, 2014 (2d) |
| Aug 26, 2014 | AVNR | ↓ Sell10b5-1 | 2,110 | $6.10 | $13K | Direct | Aug 28, 2014 (2d) |
| May 16, 2014 | AVNR | ↓ Sell | 11,900 | $4.88 | $58K | By Individual Retirement Account | May 16, 2014 (0d) |
| May 14, 2014 | AVNR | ↓ Sell | 25,596 | $5.13 | $131K | Direct | May 16, 2014 (2d) |
| Dec 18, 2013 | AVNR | ↓ Sell | 2,450 | $2.63 | $6K | Direct | Dec 20, 2013 (2d) |
| May 15, 2013 | AVNR | ↓ Sell | 77,700 | $3.29 | $255K | Direct | May 17, 2013 (2d) |
| Dec 3, 2012 | AVNR | ↓ Sell | 2,845 | $2.55 | $7K | Direct | Dec 5, 2012 (2d) |
| Sep 17, 2012 | AVNR | ↓ Sell | 65,000 | $3.49 | $227K | Direct | Sep 19, 2012 (2d) |
| Mar 6, 2012 | AVNR | ↑ Buy | 3,000 | $2.60 | $8K | By Individual Retirement Account | Mar 7, 2012 (1d) |
| Dec 2, 2011 | AVNR | ↓ Sell | 2,676 | $2.38 | $6K | Direct | Dec 6, 2011 (4d) |
| Nov 11, 2011 | AVNR | ↓ Sell | 92,250 | $2.62 | $242K | Direct | Nov 14, 2011 (3d) |
| Dec 6, 2010 | AVNR | ↓ Sell | 13,660 | $3.79 | $52K | Direct | Dec 8, 2010 (2d) |
| Dec 3, 2010 | AVNR | ↓ Sell | 47,350 | $4.09 | $194K | Direct | Dec 3, 2010 (0d) |
| Aug 11, 2010 | AVNR | ↓ Sell | 28,250 | $3.11 | $88K | Direct | Aug 13, 2010 (2d) |
| Mar 16, 2010 | AVNR | ↓ Sell | 15,518 | $2.08 | $32K | Direct | Mar 17, 2010 (1d) |
| Feb 24, 2009 | AVNR | ↑ Buy | 11,900 | $0.44 | $5K | Indirect | Feb 25, 2009 (1d) |
| May 19, 2005 | CGCP | ↑ Buy | 20,000 | $0.43 | $9K | Direct | May 19, 2005 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Christine Ocampo's insider trades
Christine Ocampo is See Remarks at Novus Therapeutics (NVUS). Since May 19, 2005, Christine has reported 4 open-market purchases worth $122K and 16 sales worth $2.5M on SEC Form 4. There have been no open-market trades in the last 12 months.
1 sale (1% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include grants and awards (14 filings), option exercises (7 filings), shares returned to the company (1 filing), inherited shares (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NVUS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.